SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000850261-18-000031
Filing Date
2018-08-09
Accepted
2018-08-09 17:21:13
Documents
106
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne6301810-q.htm 10-Q 1196176
2 EXHIBIT 12.1 exhibit121.htm EX-12.1 36046
3 EXHIBIT 31.1 exhibit311.htm EX-31.1 12179
4 EXHIBIT 31.2 exhibit312.htm EX-31.2 11993
5 EXHIBIT 32.1 exhibit321.htm EX-32.1 13294
  Complete submission text file 0000850261-18-000031.txt   9730235

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srne-20180630.xml EX-101.INS 1717681
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20180630.xsd EX-101.SCH 91267
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srne-20180630_cal.xml EX-101.CAL 108463
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srne-20180630_def.xml EX-101.DEF 680400
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20180630_lab.xml EX-101.LAB 1041354
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20180630_pre.xml EX-101.PRE 836674
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 181006388
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services